Company profile
Ticker
ADOB
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Adorbs Inc., Soul Biotechnology Corp
SEC CIK
Corporate docs
Subsidiaries
MySpray Therapeutics Inc. ...
Latest filings (excl ownership)
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
13 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
27 Oct 23
DEF 14C
Information statement
4 Oct 23
10-Q
2023 Q2
Quarterly report
27 Sep 23
PRE 14C
Preliminary information
15 Sep 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
RW
Registration withdrawal request
11 Aug 23
S-1
IPO registration
7 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
Latest ownership filings
No filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 10.57 k | 10.57 k | 10.57 k | 10.57 k | 10.57 k | 10.57 k |
Cash burn (monthly) | 66.33 | 4.27 k | 136.65 k | 130.03 k | 2.65 k | 970.50 |
Cash used (since last report) | 394.93 | 25.45 k | 813.59 k | 774.15 k | 15.79 k | 5.78 k |
Cash remaining | 10.18 k | -14.88 k | -803.02 k | -763.57 k | -5.22 k | 4.80 k |
Runway (months of cash) | 153.5 | -3.5 | -5.9 | -5.9 | -2.0 | 4.9 |